Source: Korea Biomedical Review

Mundipharma: Samjin Pharm and Mundipharma Korea to co-promote Norspan patch

Samjin Pharmaceuticals said Wednesday that it has signed a business agreement with Mundipharma Korea on the adhesive painkiller Norspan patch.Under the agreement, the two companies will jointly conduct sales and marketing for the entire distribution channel, including general hospitals, quasi-genera

Read full article »
Est. Annual Revenue
$1.0-5.0B
Est. Employees
1.0-5.0K
Marc Princen's photo - CEO of Mundipharma

CEO

Marc Princen

CEO Approval Rating

82/100

Read more